Randomized, open-label, phase 2 study of andecaliximab plus nivolumab versus nivolumab alone in advanced gastric cancer identifies biomarkers associated with survival
======================================================================================================================================================================

* Manish A Shah
* David Cunningham
* Jean-Philippe Metges
* Eric Van Cutsem
* Zev Wainberg
* Emon Elboudwarej
* Kai-Wen Lin
* Scott Turner
* Marianna Zavodovskaya
* David Inzunza
* Jinfeng Liu
* Scott D Patterson
* Jingzhu Zhou
* Jing He
* Dung Thai
* Pankaj Bhargava
* Carrie Baker Brachmann
* Daniel V T Cantenacci